English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/211552
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis

AuthorsMadoz-Gúrpide, Juan ; Lopez-Serra, P.; Martínez-Torrecuadrada, Jorge Luis; Sanchez, L.; Lombardía, Luis; Casal, J. Ignacio
KeywordsGelatinase-associated lipocalin
Gene-expression profiles
T-cell lymphoma
Oligonucleotide arrays
Gel-electrophoresis
Escherichia-coli
CDNA microarrays
Human proteins
Cloning
Identification
Issue DateAug-2006
PublisherAmerican Society for Biochemistry and Molecular Biology
CitationMol Cell Proteomics 5 (8)1471-83 (2006)
AbstractMultiple factors are involved in the translation of functional genomic results into proteins for proteome research and target validation on tumoral tissues. In this report, genes were selected by using DNA microarrays on a panel of colorectal cancer (CRC) paired samples. A large number of up-regulated genes in colorectal cancer patients were investigated for cellular location, and those corresponding to membrane or extracellular proteins were used for a non-biased expression in Escherichia coli. We investigated different sources of cDNA clones for protein expression as well as the influence of the protein size and the different tags with respect to protein expression levels and solubility in E. coli. From 29 selected genes, 21 distinct proteins were finally expressed as soluble proteins with, at least, one different fusion protein. In addition, seven of these potential markers (ANXA3, BMP4, LCN2, SPARC, SPP1, MMP7, and MMP11) were tested for antibody production and/or validation. Six of the seven proteins (all except SPP1) were confirmed to be overexpressed in colorectal tumoral tissues by using immunoblotting and tissue microarray analysis. Although none of them could be associated to early stages of the tumor, two of them (LCN2 and MMP11) were clearly overexpressed in late Dukes' stages (B and C). This proteomic study reveals novel clues for the assembly of a robust and highly efficient high throughput system for the validation of genomic data. Moreover it illustrates the different difficulties and bottlenecks encountered for performing a quick conversion of genomic results into clinically useful proteins.
Description13 p.-5 fig.-3 tab.
Publisher version (URL)https://doi.org/10.1074/mcp.M600048-MCP200
URIhttp://hdl.handle.net/10261/211552
DOI10.1074/mcp.M600048-MCP200
ISSN1535-9476
E-ISSN1535-9484
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
Mol & Cel Prot_Madoz-Gúrpide_2006.pdfArtículo principal2,26 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.